Research Leading to Ozempic Honored by 2024 Lasker Awards
WEB1 day ago · Research That Led to Obesity Drugs Wins Major Medical Prize. Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V ...
Ozempic, Wegovy linked to severe medical conditions ... - NBC News
WEBCompared to people taking bupropion-naltrexone, people taking a GLP-1 drug had a higher risk of pancreatitis, bowel obstruction and gastroparesis, the study found.
The winding, fitful path to weight loss drug Ozempic - Medical …
WEB12 hours ago · Starting in the 1990s, Knudsen, the head of GLP-1 therapeutics at Novo Nordisk, and her team built on these breakthroughs to develop treatments for diabetes (Ozempic) and obesity (Wegovy ...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
WEBThe drug contains the GLP-1 hormone, a key ingredient in Ozempic and Wegovy, in addition to glucagon. Altimmune released data from a phase 2 trial of 391 adults with obesity or who are...
New study ties weight-loss drugs Wegovy, Ozempic to serious ...
WEBOct 5, 2023 · A study published in JAMA found that GLP-1 inhibitor drugs for diabetes and weight loss may increase the risk of pancreatitis, intestinal blockage and stomach paralysis. The drugs include Novo...
Opinion | Is Obesity a Disease? It’s Complicated in the Age of Ozempic …
WEB21 hours ago · Dr. Rubino’s idea to tackle this topic predated the widespread popularity of medications like Ozempic, known as GLP-1 drugs, stemming instead from his practice as a bariatric surgeon.
Drugs like Wegovy and Ozempic may help prevent cancer : Shots
WEBAug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
More fiber in the diet may help boost levels of GLP-1, an Ozempic …
WEBOct 30, 2023 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
1 in 8 adults in the US has taken Ozempic or another GLP-1 drug, …
WEBMay 10, 2024 · About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people –...
As Semaglutide’s Popularity Soars, Rare but Serious Adverse …
WEBThe article reviews the rare but serious adverse effects of semaglutide, a GLP-1 receptor agonist for weight management and diabetes, and compares it with other drugs in the same class. It also discusses the FDA approval of tirzepatide, a new antiobesity drug with two active ingredients.